NPI registry status
Active
2026 NPPES data Nuclear Medicine Physician NPI 1487976668 M.D.
Verify on CMS → Mohammad Rezvani, M.D.
Nuclear Medicine Physician in Los Angeles, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 906 in Nuclear Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
8K
Medicare Part D claims · 389 beneficiaries · Nuclear Medicine Physician avg: 881
Generic prescribing
86%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.5/100
▼ 9 pts below national avg 83.1 · Mid-tier
Industry payments
$39.92
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mohammad Rezvani, M.D. reported a CMS MIPS final score of 74.5/100 - below the 83.1 national average - and filed 8,036 Medicare Part D claims in 2023.
- 74.5/100
- MIPS score · -9 vs avg
- 8K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mohammad Rezvani, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 12th percentile higher than 12% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mohammad Rezvani, M.D. sits
This provider among nuclear medicine physician peers
Across the 25 nuclear medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mohammad Rezvani, M.D. writes more Part D claims than 92% of them and scores higher on MIPS quality than 16% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one nuclear medicine physician peer from a representative sample of 24; the gold marker is Mohammad Rezvani, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mohammad Rezvani, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mohammad Rezvani, M.D.?
Below national averagePrimary specialty
Nuclear Medicine Physician
Medicare Part D claims
8,036 9× vs specialty avg
MIPS final score
74.5/100 8.6 pts vs avg
Specialty distribution in California
How Nuclear Medicine Physician compares to other specialties among California providers
Medicare quality performance, MIPS
Mohammad Rezvani, M.D.'s 2023 MIPS final score plotted against the Nuclear Medicine Physician national average
- MIPS Final Score
- 74.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Nuclear Medicine Physician) - 74.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mohammad Rezvani, M.D. appears in the CMS NPPES registry as a Nuclear Medicine Physician provider holding M.D. credentials at 3392 MOTOR AVE, Los Angeles, CA, 90034, with a listed phone of (310) 858-5090. NPI 1487976668 was issued on 02/16/2010.
Medicare Part D records for calendar year 2023 show 8,036 prescription claims written by this provider, covering 389 Medicare beneficiaries and totaling roughly $762K in drug spend, split 13% brand-name and 86% generic by claim count, with an opioid prescribing rate of 2.9%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.5/100 for the 2023 performance year (Quality 68.4, Cost 14.9), compared with the national average of 83.1.
Nuclear Medicine Physician is a narrow specialty nationwide, with 906 enrolled providers across 48 states and an average of 881 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487976668 |
|---|---|
| Specialty | Nuclear Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 02/16/2010 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
74.5065
Final Score
Avg: 83.1
68.4372
Quality
14.918
Cost
98
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mohammad Rezvani, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$40
Largest payer
Otsuka America Pharmaceutical, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Mohammad Rezvani, M.D.. To verify Mohammad Rezvani, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Mohammad Rezvani, M.D. - brand share 13.0%
Nuclear Medicine Physician average
13% brand-name claims vs 86% generic, on 8,036 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
8,036
Total Claims
$762K
Total Drug Cost
389
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 11,191
- Total Day Supply
- 272,750
- Brand vs Generic
- 13% brand / 86% generic
- Brand Drug Cost
- $559K
- Generic Drug Cost
- $201K
- Opioid Claims
- 232 (2.9% rate)
- Antibiotic Claims
- 221
Patient Demographics
- Average Patient Age
- 72.0 years
- Avg HCC Risk Score
- 2.68
- Gender Split
- 52% female / 48% male
- Age Distribution
- <65: 60, 65-74: 172, 75-84: 104, 85+: 53
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mohammad Rezvani, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
487 claims
- Amlodipine Besylate
Amlodipine Besylate
300 claims
- Levothyroxine Sodium
Levothyroxine Sodium
220 claims
- Metformin Hcl
Metformin Hcl
215 claims
- Gabapentin 182
Gabapentin
182 claims
- Furosemide 179
Furosemide
179 claims
- Losartan Potassium 178
Losartan Potassium
178 claims
- Pantoprazole Sodium 169
Pantoprazole Sodium
169 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 487 |
| Amlodipine Besylate | 300 |
| Levothyroxine Sodium | 220 |
| Metformin Hcl | 215 |
| Gabapentin | 182 |
| Furosemide | 179 |
| Losartan Potassium | 178 |
| Pantoprazole Sodium | 169 |
| Escitalopram Oxalate | 167 |
| Eliquis Apixaban | 149 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nuclear Medicine Physician Overview
How Mohammad Rezvani, M.D. fits within the Nuclear Medicine Physician landscape nationally.
906
Nuclear Medicine Physician Providers in US
48
States with Nuclear Medicine Physician
881
Avg Claims per Provider
Mohammad Rezvani, M.D.'s 8,036 claims are above the specialty average of 881.
Nearby Nuclear Medicine Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Rezvani.
Dr. Fabio Almeida
M.D.
Roseville, CA
Dr. Nelson Arnstein
MD
Bellflower, CA
Dr. Geetha Ashok
MD
Panorama City, CA
Dr. Charles Barnett
M.D.
Mather, CA
Dr. Ernest Belezzuoli
M.D.
San Diego, CA
Compare Nuclear Medicine Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Nuclear Medicine Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Mohammad Rezvani, M.D.'s specialty? ▼
Mohammad Rezvani, M.D. specializes in Nuclear Medicine Physician and practices in Los Angeles, California. Credentials: M.D..
How much does Mohammad Rezvani, M.D. prescribe under Medicare Part D? ▼
In 2023, Mohammad Rezvani, M.D. wrote 8,036 Medicare Part D claims totaling $762K in drug costs for 389 beneficiaries.
What is Mohammad Rezvani, M.D.'s Medicare quality score? ▼
Mohammad Rezvani, M.D. has a CMS MIPS Final Score of 74.5/100 (Quality: 68.4, Cost: 14.9). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mohammad Rezvani, M.D. located? ▼
Mohammad Rezvani, M.D. is located at 3392 MOTOR AVE, Los Angeles, CA, 90034. Phone: (310) 858-5090.
What is Mohammad Rezvani, M.D.'s NPI number? ▼
Mohammad Rezvani, M.D.'s National Provider Identifier (NPI) is 1487976668, issued on 02/16/2010.
Does Mohammad Rezvani, M.D. prescribe more brand-name or generic drugs? ▼
Mohammad Rezvani, M.D.'s prescribing is 13% brand-name and 86% generic drugs by claim count, with $559K in brand drug costs.
Does Mohammad Rezvani, M.D. prescribe opioids? ▼
Yes, Mohammad Rezvani, M.D. had 232 opioid claims in 2023 with an opioid prescribing rate of 2.9%.
How many Nuclear Medicine Physician providers are there in the US? ▼
There are 906 Nuclear Medicine Physician providers across 48 states in the US. The average Nuclear Medicine Physician provider writes 881 Medicare Part D claims per year.
What drugs does Mohammad Rezvani, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Mohammad Rezvani, M.D.'s most frequently prescribed drugs include Atorvastatin Calcium, Amlodipine Besylate, Levothyroxine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mohammad Rezvani, M.D. accept Medicare? ▼
Mohammad Rezvani, M.D. appears in CMS Medicare data with 8,036 Part D claims and 389 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mohammad Rezvani, M.D.'s credentials? ▼
Mohammad Rezvani, M.D.'s NPI is 1487976668 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.